Biohaven Interest Expense vs Total Operating Expenses Analysis
BHVN Stock | USD 40.69 0.79 1.98% |
Biohaven Pharmaceutical financial indicator trend analysis is way more than just evaluating Biohaven Pharmaceutical prevailing accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Biohaven Pharmaceutical is a good investment. Please check the relationship between Biohaven Pharmaceutical Interest Expense and its Total Operating Expenses accounts. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Biohaven Pharmaceutical Holding. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in real.
Interest Expense vs Total Operating Expenses
Interest Expense vs Total Operating Expenses Correlation Analysis
The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Biohaven Pharmaceutical Interest Expense account and Total Operating Expenses. At this time, the significance of the direction appears to have almost identical trend.
The correlation between Biohaven Pharmaceutical's Interest Expense and Total Operating Expenses is 0.91. Overlapping area represents the amount of variation of Interest Expense that can explain the historical movement of Total Operating Expenses in the same time period over historical financial statements of Biohaven Pharmaceutical Holding, assuming nothing else is changed. The correlation between historical values of Biohaven Pharmaceutical's Interest Expense and Total Operating Expenses is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Interest Expense of Biohaven Pharmaceutical Holding are associated (or correlated) with its Total Operating Expenses. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Total Operating Expenses has no effect on the direction of Interest Expense i.e., Biohaven Pharmaceutical's Interest Expense and Total Operating Expenses go up and down completely randomly.
Correlation Coefficient | 0.91 |
Relationship Direction | Positive |
Relationship Strength | Very Strong |
Interest Expense
The cost incurred by an entity for borrowed funds, including loans, bonds, or lines of credit.Total Operating Expenses
The total costs associated with the day-to-day operations of a business, excluding the cost of goods sold but including selling, general, and administrative expenses.Most indicators from Biohaven Pharmaceutical's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Biohaven Pharmaceutical current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Biohaven Pharmaceutical Holding. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in real. As of the 4th of May 2024, Enterprise Value is likely to grow to about 3.2 B, while Selling General Administrative is likely to drop about 61 M.
2021 | 2022 | 2023 | 2024 (projected) | Reconciled Depreciation | 1.4M | 1.4M | 6.9M | 7.3M | Cost Of Revenue | 91.7M | 1.4M | 3.4M | 3.2M |
Biohaven Pharmaceutical fundamental ratios Correlations
Click cells to compare fundamentals
Biohaven Pharmaceutical Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Biohaven Pharmaceutical fundamental ratios Accounts
2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
Total Assets | 344.3M | 111.5M | 142.1M | 661.8M | 513.2M | 347.2M | |
Other Current Liab | 52.1M | 27.1M | 37.2M | 79.3M | 36.5M | 38.6M | |
Total Current Liabilities | 66.2M | 29.9M | 41.9M | 90.0M | 55.4M | 49.1M | |
Total Stockholder Equity | (7.4M) | 16.8M | 34.7M | 538.8M | 428.0M | 449.4M | |
Property Plant And Equipment Net | 8.2M | 13.6M | 18.2M | 52.4M | 48.6M | 51.0M | |
Net Debt | (316.7M) | 185.0M | 550.7M | (174.3M) | (218.8M) | (207.9M) | |
Retained Earnings | (972.4M) | (1.7B) | (2.6B) | (91.1M) | (499.3M) | (524.3M) | |
Accounts Payable | 14.1M | 2.8M | 4.8M | 10.7M | 15.6M | 10.0M | |
Cash | 316.7M | 82.5M | 76.1M | 204.9M | 249.7M | 151.5M | |
Non Current Assets Total | 16.0M | 21.7M | 47.2M | 74.8M | 70.8M | 40.6M | |
Non Currrent Assets Other | 7.8M | 1.0M | 3.2M | 2.6M | 2.4M | 4.2M | |
Cash And Short Term Investments | 316.7M | 82.5M | 76.1M | 465.3M | 383.1M | 270.2M | |
Liabilities And Stockholders Equity | 344.3M | 111.5M | 142.1M | 661.8M | 513.2M | 347.2M | |
Non Current Liabilities Total | 285.5M | 4.8M | 5.4M | 33.0M | 29.8M | 55.3M | |
Other Current Assets | 11.6M | 10K | 2.1M | 19.3M | 45.7M | 47.9M | |
Other Stockholder Equity | 83.5M | 98.9M | 169.7M | 13.9M | 39.8M | 73.8M | |
Total Liab | 351.7M | 34.7M | 47.4M | 123.0M | 85.2M | 91.0M | |
Total Current Assets | 328.3M | 89.8M | 94.8M | 587.0M | 442.4M | 306.6M | |
Common Stock | 881.4M | 1.2B | 1.7B | 615.7M | 887.5M | 970.6M |
Pair Trading with Biohaven Pharmaceutical
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Biohaven Pharmaceutical position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Biohaven Pharmaceutical will appreciate offsetting losses from the drop in the long position's value.Moving together with Biohaven Stock
0.65 | VTYX | Ventyx Biosciences Financial Report 9th of May 2024 | PairCorr |
Moving against Biohaven Stock
0.54 | SABSW | SAB Biotherapeutics | PairCorr |
0.48 | MRK | Merck Company Financial Report 6th of August 2024 | PairCorr |
The ability to find closely correlated positions to Biohaven Pharmaceutical could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Biohaven Pharmaceutical when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Biohaven Pharmaceutical - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Biohaven Pharmaceutical Holding to buy it.
The correlation of Biohaven Pharmaceutical is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Biohaven Pharmaceutical moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Biohaven Pharmaceutical moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Biohaven Pharmaceutical can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Biohaven Pharmaceutical Holding. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in real. You can also try the Aroon Oscillator module to analyze current equity momentum using Aroon Oscillator and other momentum ratios.
Complementary Tools for Biohaven Stock analysis
When running Biohaven Pharmaceutical's price analysis, check to measure Biohaven Pharmaceutical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Biohaven Pharmaceutical is operating at the current time. Most of Biohaven Pharmaceutical's value examination focuses on studying past and present price action to predict the probability of Biohaven Pharmaceutical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Biohaven Pharmaceutical's price. Additionally, you may evaluate how the addition of Biohaven Pharmaceutical to your portfolios can decrease your overall portfolio volatility.
Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
Transaction History View history of all your transactions and understand their impact on performance | |
AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities | |
Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities |
Is Biohaven Pharmaceutical's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Biohaven Pharmaceutical. If investors know Biohaven will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Biohaven Pharmaceutical listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (5.73) | Return On Assets (0.46) | Return On Equity (0.84) |
The market value of Biohaven Pharmaceutical is measured differently than its book value, which is the value of Biohaven that is recorded on the company's balance sheet. Investors also form their own opinion of Biohaven Pharmaceutical's value that differs from its market value or its book value, called intrinsic value, which is Biohaven Pharmaceutical's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Biohaven Pharmaceutical's market value can be influenced by many factors that don't directly affect Biohaven Pharmaceutical's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Biohaven Pharmaceutical's value and its price as these two are different measures arrived at by different means. Investors typically determine if Biohaven Pharmaceutical is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Biohaven Pharmaceutical's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.